par Partridge, Ann A.H.;Gelber, Shari;Piccart-Gebhart, Martine
;Focant, Florine;Scullion, Matthew;Holmes, Eileen;Winer, Eric E.P.;Gelber, Richard
Référence Journal of clinical oncology, 31, 21, page (2692-2698)
Publication Publié, 2013-07

Référence Journal of clinical oncology, 31, 21, page (2692-2698)
Publication Publié, 2013-07
Article révisé par les pairs
Titre: |
|
Auteur: | Partridge, Ann A.H.; Gelber, Shari; Piccart-Gebhart, Martine; Focant, Florine; Scullion, Matthew; Holmes, Eileen; Winer, Eric E.P.; Gelber, Richard |
Informations sur la publication: | Journal of clinical oncology, 31, 21, page (2692-2698) |
Statut de publication: | Publié, 2013-07 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Age Factors | |
Antibodies, Monoclonal, Humanized -- therapeutic use | |
Antineoplastic Agents -- therapeutic use | |
Breast Neoplasms -- drug therapy -- enzymology -- pathology | |
Chemotherapy, Adjuvant | |
Female | |
Humans | |
Proportional Hazards Models | |
Receptor, ErbB-2 -- metabolism | |
Retrospective Studies | |
Treatment Outcome | |
Young Adult | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2012.44.1956 | |
info:pii/JCO.2012.44.1956 | |
info:scp/84886615995 | |
info:pmid/23752109 |